Deprecated: The called constructor method for WP_Widget in FreestockchartsDynamic_Widget is deprecated since version 4.3.0! Use __construct() instead. in /var/www/wp-includes/functions.php on line 4952
Human Genome Sciences Anthrax Deal in 2003

1999 Biotech Superstar Got Bailed Out By Anthrax antitoxin?!

The famous Company that was going to revolutionize drug discovery was saved in 2003 by a government funded bioterror program for Anthrax and later a Lupus drug.

Anthrax drug brings $334 million to Pentagon advisor’s biotech firm –

Human Genome Sciences was sold to Glaxo (GSK) in August 2012 for $3.6B. Glaxo was already partnered with HGSI for the Lupus drug Benlysta. As of March 31, 2012, since inception Human Genome Sciences accumulated a deficit of $2,894, 498 with a book value of $377M. Over 19.5 years since its IPO in 1993 the stock appreciated 145% or about 7% a year not including the cost of money. The stock peaked in 1999 at $100/share when the Company was on the forefront of “druggable genes” or the molecular basis of disease.

Benlysta, a Lupus Drug, Is Approved by F.D.A. –

Human Genome Sciences: NASDAQ:HGSI quotes & news – Google Finance


Pin It on Pinterest